Safety of Alemtuzumab in RRMS Patients in the Period Following Lymphocyte Repopulation: Clinical Trial and Postmarketing Experience

Saved in:
Bibliographic Details
Published inEUROPEAN JOURNAL OF NEUROLOGY Vol. 27; p. 336
Main Authors Jones, J, Coml, G, Fernandez, O, Kappos, L, Havrdova, EK, Laganke, C, Greja-Guevara, C, Piehl, F, Traboulsee, A, Vermersch, P, Wiendl, I, Ziemssen, T, Poole, E, Coles, AJ
Format Conference Proceeding
LanguageEnglish
Published 2020
Subjects
Medicin och hälsovetenskap
Online AccessGet full text

Cover

More Information
ISSN:1351-5101